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Abstract
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) was identified in humans in 2012. Dromedary camels were consid-
ered as the major reservoir of the virus throw several studies. Tunisian dromedary camels were implicated in a serological survey 
and a seropositivity reaching 100% was observed among some of them. Therefore, more investigations are necessary to look for 
the current infection situation. In this study, we aimed to detect the MERS-CoV virus in our camels by molecular technics. Blood 
and nasal swabs samples from 64 dromedary camels from 4 Tunisian provinces were collected during June 2014 and April 2015. 
All the animals tested negative by real time reverse transcriptase–polymerase chain reaction assay (RT-PCR). These findings 
could not confirm the absence of MERS-CoV active shading among the Tunisian camel population and more researches should 
be carried on to survey dromedary camels in Tunisia and its neighboring countries.
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Résumé 
Le Coronavirus du syndrome respiratoire du Moyen-Orient (MERS-CoV) a été identifié chez l’Homme pour la première fois en 
2012. A travers plusieurs études, les dromadaires ont été alors considérés comme étant le réservoir majeur du virus. Une enquête 
sérologique chez les dromadaires en Tunisie a permis de démontrer une séropositivité allant jusqu’à 100% chez certains sujets 
étudiés. Ainsi, des recherches supplémentaires semblent être nécessaires pour évaluer l’état d’infection actuel du pays. A travers 
cette étude, nous visons, par le biais de techniques moléculaires, la détection du virus (MERS-CoV) chez nos dromadaires tunisiens. 
Durant la période s’étalant entre juin 2014 et avril 2015, des échantillons de sang et des écouvillonnages nasaux ont été prélevés 
à partir de 64 individus prévenant de 4 gouvernorats. L’essai de la détection moléculaire, en utilisant la technique d’amplification 
génomique en chaîne de polymérase avec transcriptase inverse (RT-PCR), a démontré que tous les sujets étudiés ont donné un 
réponse négative. Cependant, ces résultats ne peuvent pas confirmer l’absence d’une excrétion active du virus chez la population 
cameline tunisienne, raison pour laquelle d’autres investigations doivent être enchaînées pour surveiller l’état d’infection cameline 
par le MERS-CoV non seulement en Tunisie mais également dans les pays voisins.
Mots-clés: Le Syndrome Respiratoire du Moyen-Orient (SRMO), dromadaires, Tunisie, RT-PCR, surveillance animale, Coro-
navirus (CoVs), détection moléculaire
Détection moléculaire du Coronavirus du Syndrome Respiratoire du Moyen-Orient (MERS-CoV) 
chez les dromadaires tunisiens (Camelus dromedarius)
INTRODUCTION
In 2012, a new Coronavirus, Middle East Respiratory 
Syndrome Coronavirus (MERS-CoV), was isolated from 
a Saudi Arabian patient (Zaki et al., 2012). It causes se-
vere lower respiratory tract infection in humans (Zaki et 
al., 2012, WHO-MERS-CoV Research Group, 2013). As 
of 30 January 2017, 1.888 cases of laboratory-confirmed 
MERS have been reported to the World Health Organiza-
tion (WHO) (WHO official web site, assessed: 31 January 
2017). Although bats are shown to harbor CoVs phyloge-
netically related to MERS-CoV (Chan et al., 2015), the 
discovery of closely related viruses and virus-neutralizing 
antibodies in dromedary camels (Camelus dromedarius) 
has led to the hypothesis that they are the major reservoir 
of MERS-CoV and are implicated in direct or indirect 
transmission to human beings (Zumla et al., 2015, Crameri 
et al., 2015).
In 2014, a serological survey has invested geographic 
distribution of MERS-CoV among dromedary camels in 
Africa including sera from dromedary camels from Tuni-
sia (Reusken et al., 2014). Surprisingly, a seropositivity 
ranging from 36% in Sidi Bouzid province to as much as 
100% in Kebili province was observed among Tunisian 
dromedary camels, which confirmed that they must have 
had previous infection with MERS-CoV. These evidences 
have raised public health concerns and further investiga-
tions seemed to be needed for management and control 
recommendations. 
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The purpose of this study is to investigate a current shading 
of MERS-CoV among camels from Tunisia by a molecular 
detection technics in order to implement adequate sanitary 
and control measures. 
MATERIALS AND METHODS
Samples Collection
Blood and nasal swabs samples were collected from 64 
apparently healthy dromedary camels. Since the infection 
epidemiology was not well understood, animal selection 
was hazardous and selected animals were of different age, 
breed and sex and from four Tunisian provinces (Figure 1). 
However, we intend to take samples from the same farms 
in two provinces (Sousse and Kebili) that showed positive 
results in the previous serological survey (Reusken et al, 
2014).  Samples were collected on the 3rd June 2014, 10th 
October 2014, 3rd November 2014 and 22nd April 2015, 
respectively (Table 1). The ages of the animals ranged 
from 7 months to 14 years (26 juvenile < 2 years of age; 
38 adults > 2 years of age). Blood samples were taken by 
jugular vein puncture according to local laws. Nasal swabs 
were taken from the two nasal cavities of each animal 
and put in tubes containing viral transport medium. After 
sampling, all the samples were stored at 4°C and shipped 
to the microbiological laboratory of the Charles Nicolle 
Hospital in Tunis, Tunisia in less than 24 hours.
Molecular detection
RNAs were extracted from the nasal swabs and the plas-
ma’s samples with the use of the QIAamp Viral RNA Mini 
Kit (Qiagen), according to the manufacturer’s instruc-
tions. Eluted RNAs were screened for the MERS-CoV 
upstream region of the E gene (upE region) with the use 
of real-time RT-PCR, as described previously (Haagmans 
et al., 2014; Corman et al., 2012).
RESULTS
Absence of RNA MERS-CoV in Tunisian dromedary 
camels
Real time RT-PCR Up-E assay was used to detect MERS-
CoV RNA in Tunisian camels. Among the 64 studied 
dromedary camels, we note that 40.6 % of the individuals 
are juveniles (<2 years old) while 59.4 % are adults (> 2 
years old).
As all the analyzed animals showed a negative result 
for MERS-CoV RNA detection, including animals that 
were sampled from Kebili and Sousse provinces where a 
seropositivity of 40% and 100% was previously reported 
(Reusken et al., 2014), only results from selected plasma 
and nasal swabs samples (at least 5 individuals from each 
region except Ben Guerdene province) are given in table 2 
to permit a clearer presentation of the findings (Figure 2). 
As we noticed, only positive control sample showed a 
positive result. 
Figure 1: The 4 regions sampled in this study 
(Map adapted from http://d-maps.com/index.php)
DISCUSSION
This study aimed to find out whether MERS-CoV is ac-
tually circulating among camels in Tunisia, after finding 
specific antibodies against MERS-CoV in some of these 
animals, as previously reported (Reusken et al., 2014). 
Our work was based only on molecular technics that allow 
a direct detection of the virus and so the detection of an 
eventual recent infection, whereas, serological methods 
as used in the previous survey (Reusken et al., 2014) do 
not offer this precision.
MERS-CoV transmission and ecology are not yet well 
know and different studies are actually focusing on these 
properties in order to understand its complex epidemiol-
ogy (Funk et al., 2016). During our work animal sampling 
was hazardous and we have especially focused on ap-
parently healthy dromedary camels. However, different 
considerations related to the virus properties were missed. 
First of all, camels infected with MERS-CoV can develop 
rhinitis or show no signs of infection (Zumla et al., 2015). 
Besides, despite that both adults and calves can be infected 
(Hemida et al., 2014); juvenile dromedary camels might at 
higher risk of contracting the virus than adults due to their 
naïve status (Mohd et al., 2016). In fact, in 2017 in Jordan; 
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van Doremalen et al., (2017) detected a high prevalence of 
MERS-CoV in dromedary camels younger than 3 years. 
In addition to that, calving season is believed as a period 
of higher risk for virus transmission (Funk et al., 2016). 
These elements indicate that same camels with active virus 
shading and that capable of showing a positive result might 
be missed while sampling. Actually, the probability of 
finding dromedary camels with virus excretion by the time 
of sampling would be higher if we have concentrated on 
juvenile individuals rather than adults, animals expressing 
respiratory disease rather than apparently healthy camels 
and if we have chosen calving season as the best period 
of collecting samples. Moreover, it should be mentioned 
that by gathering these factors to increase the probabil-
Table 1: Camel samples collected in this study
Animal number Date of collection Animal originated from
23 03-06-2014 Sousse (central-east of Tunisia)
10 10-10-2014 Gafsa (southwest Tunisia)
2 03-11-2014 Ben Gardane (south eastern Tunisia) 
29 22-04-2015 Kebili (south-western Tunisia)
Table 2: RT-PCR results of selected plasma and nasal swabs’ samples
Camel’s number Region Age* Sexe** RT-PC on plasma samples RT-PCR on nasal swabs’ samples
1 Sousse A M Neg Neg
2 Sousse A M Neg Neg
3 Sousse A F Neg Neg
4 Sousse A F Neg Neg
5 Sousse A F Neg Neg
24 Gafsa J M Neg Neg
25 Gafsa J M Neg Neg
26 Gafsa J M Neg Neg
27 Gafsa A F Neg Neg
28 Gafsa A F Neg Neg
34 Ben Guerdene A F Neg Neg
35 Ben Guerdene J M Neg Neg
60 Kebili A F Neg Neg
61 Kebili A F Neg Neg
62 Kebili A M Neg Neg
63 Kebili A M Neg Neg
64 Kebili A M Neg Neg
*Camel age range: J, juvenile ≤2 years of age; A, adult >2 years of age
**Camel sexes: M, Male; F, Female
Figure 2: Real time RT-PCR results of dromedary camels from Kebili region
263 Rev. Mar. Sci. Agron. Vét. (2018) 6 (2):260-264
ity of discovering sick animal replicating the virus, the 
likelihood of falling ill during pre-treatment would also 
increase. Hence, we must respect necessary biosafety 
precautions while sampling.
In the other hand, the absence of RNA MERS-CoV detec-
tion and high seropositivity reported in the previous study 
(Reusken et al., 2014) may indicate only a past contact of 
Tunisian camels with the virus. In fact, seropositivity was 
noted in camels in Somalia and Sudan using archived se-
rum samples accumulated during the past 30 years (Müller 
et al., 2014). The presence of antibodies in archived sam-
ples indicates that this infection is not recent in Africa. In 
addition to that, serological surveys investing dromedaries 
of the Canary Islands revealed a decrease in specific sero-
positivity between 2013 and 2015. While throw the first 
study a seropositivity rate of 14% was recorded (Reusken 
et al., 2013), the second study showed a lower rate (4.1%) 
(Gutiérrez et al., 2015). These findings indicate that these 
dromedaries had contacted the virus at same point of their 
lives; however, a current infection doesn’t exist. So, bas-
ing on these facts that confirm that MERS-CoV is a very 
immunogenic virus, additional serological studies should 
be done on different dromedary camels, especially those 
expressing clinical respiratory disease, in order to eventu-
ally demonstrate a recent infection.
The hypothesis that MERS-CoV infection in dromedaries 
in Tunisia is a very rare event is a probable idea that should 
be considered. Although Corman et al., (2014) indicated 
that MERS-CoV originated from sub-Saharan African 
bats, the MERS epidemic has started in the Middle East, 
where almost all primary cases of MERS-CoV have been 
registered. This reminds us of a particularity related to 
the dromedary farming in the Middle East. Indeed, since 
the 1960s, throw the intensification and the concentration 
of the production around cities, there have been radical 
changes in dromedary farming practices in the Arabian 
Peninsula (Gossner et al., 2016). These modifications 
in the overall dynamics of dromedary populations as 
well as the recent intensification of their breeding might 
increase the number of viral spawners and the attack rate 
in dromedary herds. As a consequence, there have been 
an increased spread of the virus among camels and so the 
augmentation of zoonotic infections from dromedaries 
to humans (Gossner et al., 2016). The circumstances of 
MERS-CoV emergence in the Middle East remind us then 
of those of the SARS-CoV in China in 2003, as particular 
conditions have also favored the transmission of the virus 
from bats to humans through encaged civets. 
CONCLUSION
Additional researches are needed to confirm or invali-
date a current infection of camel herds in Tunisia and its 
neighboring countries. Samples collection should be more 
selective basing on age, sex, symptoms and the season. 
Vigilance and specific concerned authorities’ measures 
should be kept to avoid a potential epidemic in North 
Africa. 
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